Skip to main content
Clinical Trials/CTRI/2024/05/066782
CTRI/2024/05/066782
Recruiting
Phase 2

An open clinical trial to evaluate the efficacy of Pankajakasthuri antistress formulation in the management of patients diagnosed with generalized anxiety disorder - nil

Pankajakasthuri Herbals India Pvt Ltd P0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: F41- Other anxiety disorders
Sponsor
Pankajakasthuri Herbals India Pvt Ltd P
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Pankajakasthuri Herbals India Pvt Ltd P

Eligibility Criteria

Inclusion Criteria

  • 1\.Patients of either gender in the age group between 18 \-60 years
  • 2\. Diagnosed as per ICD 10 criteria
  • 3\.Patients having Symptoms of GAD
  • 4\.Willing to enrol in study by signing Informed consent

Exclusion Criteria

  • Earlier participation in this study
  • 2\.Patients having other systemic diseases not under control
  • 3\.Patients who are not willing to sign the informed consent form
  • 4\.Patients who are diagnosed with Organic brain syndrome
  • 5\.Subjects with un controlled Endocrine disorders
  • 6\.Unable to respond properly for questionnaire or when a patient is too severely ill to answer the questions

Outcomes

Primary Outcomes

Not specified

Similar Trials